Lexaria Bioscience (LEXX) Inventory (2014 - 2023)

Lexaria Bioscience has disclosed Inventory across 10 years of filings, most recently posting $7588.0 for Q1 2023.

• Inventory for Q1 2023 came in at $7588.0, down 76.23% year-over-year; the trailing twelve-month figure through Feb 2023 was $7588.0 (down 76.23% YoY), and the FY2022 annual result was $38418.0, up 29.58% from the prior year.
• Inventory came in at $7588.0 for Q1 2023 at Lexaria Bioscience, down from $9936.0 in the prior quarter.
• In the past five years, Inventory ranged from a high of $188275.0 in Q2 2019 to a low of -$6067.0 in Q4 2020.
• The 5-year median for Inventory is $51738.0 (2021), against an average of $76415.9.
• Across the five-year window, Inventory sank 104.54% in 2020 and soared 544.47% in 2021, its largest moves.
• Lexaria Bioscience's Inventory stood at $133556.0 in 2019, then tumbled by 104.54% to -$6067.0 in 2020, then jumped by 544.47% to $26966.0 in 2021, then plunged by 63.15% to $9936.0 in 2022, then fell by 23.63% to $7588.0 in 2023.
• The last three Inventory figures came in at $7588.0 (Q1 2023), $9936.0 (Q4 2022), and $38418.0 (Q3 2022), per Business Quant data.